title: Photoleukomelanoderma possibly caused by etretinate in a patient with psoriasis.
authors.forename: Mariko
authors.initials: M
authors.lastname: Seishima
authors.forename: Yoshinao
authors.initials: Y
authors.lastname: Shibuya
authors.forename: Genichi
authors.initials: G
authors.lastname: Kato
authors.forename: Kana
authors.initials: K
authors.lastname: Watanabe
mesh_terms: D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D017454:Dermatitis, Photoallergic / Q000209:etiology* / Q000473:pathology; D004487:Edema / Q000139:chemically induced* / Q000473:pathology; D005050:Etretinate / Q000009:adverse effects*; D006801:Humans; D007641:Keratolytic Agents / Q000009:adverse effects*; D008297:Male; D008875:Middle Aged; D011087:Polycythemia Vera / Q000139:chemically induced* / Q000473:pathology; D011239:Prednisolone / Q000627:therapeutic use; D011565:Psoriasis / Q000188:drug therapy*; D012880:Skin Pigmentation / Q000187:drug effects / Q000528:radiation effects; D013473:Sunscreening Agents / Q000627:therapeutic use; D016896:Treatment Outcome
chemical_list: D000305:Adrenal Cortex Hormones; D007641:Keratolytic Agents; D013473:Sunscreening Agents; D005050:Etretinate; D011239:Prednisolone